Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q2 2020 · 10-Q
Revenue—
Net Income-$2.04M-$2.04MN/M vs Q2 2019 EPS Diluted-$0.55-$0.55N/M vs Q2 2019 Operating Income-$2,043,000N/M Operating Cash Flowderived-$3,480,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 13, 2020 · 44 d after period end